+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Emerging Drug"

CS1 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CS1 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Estetrol Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Estetrol Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Tradipitant Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tradipitant Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
KY1005 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KY1005 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Difelikefalin Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Difelikefalin Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
B244 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

B244 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
ARQ-151 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ARQ-151 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Lebrikizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lebrikizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
RG6139 (RO7247669) Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

RG6139 (RO7247669) Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
FS118 Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

FS118 Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Favezelimab (MK-4280) Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Favezelimab (MK-4280) Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Iptacopan Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Iptacopan Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
SOM3355 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SOM3355 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
SAGE-718 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAGE-718 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Ingrezza Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ingrezza Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
AMT-130 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AMT-130 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Emerging Drug market is a rapidly growing sector of the Pharmaceuticals industry. It is composed of drugs that are either newly developed or have recently been approved by regulatory bodies. These drugs are often used to treat conditions that have not been addressed by existing treatments, or to provide improved outcomes for existing treatments. Emerging Drugs are typically developed through innovative research and development, and are often the result of collaborations between pharmaceutical companies, universities, and research institutions. The Emerging Drug market is driven by the need for new treatments for diseases and conditions that have not been addressed by existing treatments. This includes diseases such as cancer, Alzheimer's, and rare diseases. Additionally, the market is driven by the need for improved treatments for existing conditions, such as diabetes, heart disease, and HIV/AIDS. Companies in the Emerging Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more